Westfield Capital Management Co. LP Has $110 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Westfield Capital Management Co. LP trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 188,130 shares of the healthcare conglomerate's stock after selling 16,324 shares during the quarter. Westfield Capital Management Co. LP's holdings in UnitedHealth Group were worth $109,996,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently made changes to their positions in UNH. International Assets Investment Management LLC raised its stake in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares in the last quarter. Swedbank AB acquired a new stake in UnitedHealth Group in the first quarter valued at approximately $1,117,462,000. Lone Pine Capital LLC bought a new position in UnitedHealth Group in the second quarter valued at about $480,903,000. Dimensional Fund Advisors LP grew its holdings in shares of UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate's stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the last quarter. Finally, Baillie Gifford & Co. raised its holdings in UnitedHealth Group by 1,125.4% in the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate's stock valued at $455,281,000 after buying an additional 821,050 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Trading Down 1.1 %

Shares of UnitedHealth Group stock opened at $590.87 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The stock has a 50 day moving average price of $582.63 and a two-hundred day moving average price of $552.95. The stock has a market capitalization of $543.77 billion, a PE ratio of 38.49, a price-to-earnings-growth ratio of 1.75 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts' consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the firm earned $6.56 earnings per share. The business's quarterly revenue was up 9.2% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.42%. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.72%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Cantor Fitzgerald raised their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an "overweight" rating in a research note on Wednesday, October 16th. Bank of America cut their target price on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating on the stock in a report on Wednesday, October 16th. Royal Bank of Canada lowered their price objective on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a research report on Wednesday, October 16th. Hsbc Global Res cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Thursday, October 17th. Finally, HSBC lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Thursday, October 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.